| |
Antibody Engineering and Directed Molecular Evolution
MilleGen is a biotech company focused on Directed Molecular Evolution (DME) and engaged in the engineering of human therapeutic antibodies. MilleGen has developed and patented a powerful DME method (MutaGen™) to generate molecular diversity which can be applied to any protein-based products. MutaGen™ protein optimisation technology occupies the heart of an efficient platform dedicated to antibody discovery. MilleGen's innovative platform, MutaGen™, combines random mutagenesis with a high throughput screening process and a bioinformatics analysis to improve human antibodies for therapeutic and diagnostic use. This platform allows selection of antibody candidates, their optimisation and their production as whole human antibody molecules which are ready to enter into clinical development.
Custom Services
MilleGen provides a know-how experience and expertise to research and industrial customers. The company offers an array of outsourcing options including High-Throughput DNA Sequencing, Bioinformatics, Gene cloning and Vector Development Services, Peptides Synthesis and Antibodies Engineering & Production.
 |
|
|
